NCT05161832

Brief Summary

Fear of movement (kinesiophobia) is a phenomenon commonly observed in people suffering from chronic pain. The aims of this project are to better understand the neurophysiological basis of this phenomenon, in particular 1) the effect of kinesiophobia (induced by nocebo intervention) on the excitability of corticospinal projections and 2) the association between kinesiophobia and top-down inhibitory mechanisms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 17, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

January 15, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2024

Completed
Last Updated

June 5, 2024

Status Verified

June 1, 2024

Enrollment Period

1.5 years

First QC Date

November 26, 2021

Last Update Submit

June 4, 2024

Conditions

Keywords

kinesiophobiaexperimental paincorticospinal excitabilityconditioned pain modulationinput output curves

Outcome Measures

Primary Outcomes (1)

  • Corticospinal excitability

    The corticospinal excitability will be assessed using motor evoked potentials at different intensity of stimulation (from motor threshold to maximal amplitude response).

    1 hour

Secondary Outcomes (1)

  • downward inhibition of pain

    1 hour

Study Arms (2)

nocebo

EXPERIMENTAL

Ultrasound with fake results of rotator cuff injury.

Behavioral: Nocebo

placebo

ACTIVE COMPARATOR

Ultrasound with fake results of the healthy rotator cuff.

Behavioral: Placebo

Interventions

NoceboBEHAVIORAL

Nocebo ultrasound with diagnosis of a fake shoulder cuff injury.

nocebo
PlaceboBEHAVIORAL

Placebo ultrasound with no diagnosis of injury.

placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years old or older
  • Healthy Volunteers
  • Capable of understanding instructions
  • Abstain from tobacco and caffeine 2 hours before data collection
  • Abstain from short-acting analgesics 6 hours before data collection

You may not qualify if:

  • A painful condition or chronic pain
  • Neurological disorders
  • Shoulder pathology
  • Skin diseases
  • Capsaicin allergy
  • Raynaud's syndrome
  • Epilepsy
  • Intracranial metallic foreign bodies, hearing aids and cochlear implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre de Recherche sur le Vieillissement

Sherbrooke, Quebec, J1H 4C4, Canada

Location

MeSH Terms

Conditions

Kinesiophobia

Interventions

Nocebo Effect

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Placebo EffectEffect Modifier, EpidemiologicEpidemiologic FactorsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Guillaume Leonard, Pr

    Université de Sherbrooke

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The principal investigators will be blinded by anonymization of the subjects and will not be present during the ultrasound. Participants will be notified of their group allocation at the end of their experimental session (after the experiment).
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants will attend two experimental sessions at the Research Center on Aging of the Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie, Sherbrooke. During the first one, the efficacy of their excitatory and inhibitory mechanisms will be assessed (thermode and cold water bath) and during the second one, their corticospinal excitability will be assessed by transcranial magnetic stimulation (before and during induced pain + placebo or nocebo echography of shoulder). Subjects will be randomized between 2 arms, nocebo (bad fake result) or placebo echography (good fake result). Participants will be allocated using minimization with 2 factors (age and sex). The two sessions will be separated by at least 48 hours.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 26, 2021

First Posted

December 17, 2021

Study Start

January 15, 2022

Primary Completion

July 29, 2023

Study Completion

January 29, 2024

Last Updated

June 5, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations